Literature DB >> 25906450

Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.

Kwang Hyuck Lee1, Jong Kyun Lee, Dong Wook Choi, In-Gu Do, Insuk Sohn, Kee-Taek Jang, Sin-Ho Jung, Jin Seok Heo, Seong Ho Choi, Kyu Taek Lee.   

Abstract

OBJECTIVES: The aim of this study was to investigate microRNAs related to postoperative prognosis of pancreatic cancer by applying microarray analysis to stored surgical specimens.
METHODS: We retrospectively analyzed the relationship between microRNA expression and postoperative survival of pancreatic cancer patients in Samsung Medical Center. After the correlation of microRNA expression between paraffin-embedded and fresh-frozen specimens was confirmed, we applied NanoString nCounter system to formalin fixed paraffin-embedded surgical specimens between 1995 September and 2010 June.
RESULTS: Paired fresh and paraffin-embedded samples from 9 patients showed a high correlation (correlation coefficient > 0.91). Among 734 microRNAs, 7 microRNAs were found to be related to postoperative overall survival of 221 pancreatic cancer patients: hsa-miR-99a, hsa-miR-150, hsa-miR-194, hsa-miR-375, hsa-miR-664, hsa-miR-342-3p, and hsa-miR-487b (P < 0.01). The prognostic microRNA signature was consistent after adjustment of clinical parameters: resection status, stages, age, sex, adjuvant treatment, pathological differentiation and postoperative carbohydrate antigen 19-9 levels.
CONCLUSIONS: We found a prediction model for postoperative prognosis of pancreatic cancer using 7 microRNA expression patterns from archived formalin-fixed paraffin-embedded surgical specimens. The methods for microRNA detection and new microRNAs detected in this study provide new insights for new research of surgically resected pancreatic cancer samples and microRNAs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25906450     DOI: 10.1097/MPA.0000000000000346

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  20 in total

Review 1.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

2.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Authors: 
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743

3.  MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.

Authors:  Yongli Zhao; Fenbao Li; Xizhong Zhang; Aiguang Liu; Jinsong Qi; Hongkai Cui; Peng Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.

Authors:  Hongchao Han; Lisheng Wang; Jie Xu; Aikun Wang
Journal:  Exp Ther Med       Date:  2018-04-10       Impact factor: 2.447

5.  Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection.

Authors:  Petr Karasek; Natalia Gablo; Jan Hlavsa; Igor Kiss; Petra Vychytilova-Faltejskova; Marketa Hermanova; Zdenek Kala; Ondrej Slaby; Vladimir Prochazka
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

6.  Hsa-miR-375 is a predictor of local control in early stage breast cancer.

Authors:  Franz Zehentmayr; Cornelia Hauser-Kronberger; Barbara Zellinger; Falk Hlubek; Claudia Schuster; Ulrich Bodenhofer; Gerd Fastner; Heinz Deutschmann; Philipp Steininger; Roland Reitsamer; Thorsten Fischer; Felix Sedlmayer
Journal:  Clin Epigenetics       Date:  2016-03-08       Impact factor: 6.551

7.  miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.

Authors:  Xuchao Zhu; Dan Li; Fei Yu; Chengyou Jia; Jing Xie; Yushui Ma; Suyun Fan; Haidong Cai; Qiong Luo; Zhongwei Lv; Lihong Fan
Journal:  Oncotarget       Date:  2016-03-15

8.  Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.

Authors:  Kai Qu; Xing Zhang; Ting Lin; Tian Liu; Zhixin Wang; Sushun Liu; Lei Zhou; Jichao Wei; Hulin Chang; Ke Li; Zheng Wang; Chang Liu; Zheng Wu
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

9.  Correlation between polymorphisms in microRNA-regulated genes and cervical cancer susceptibility in a Xinjiang Uygur population.

Authors:  Jing Fang; Ying Li; Jiayi Zhang; Mengdan Yan; Jingjie Li; Shan Bao; Tianbo Jin
Journal:  Oncotarget       Date:  2017-05-09

Review 10.  Prognostic role of microRNA-150 in various carcinomas: a meta-analysis.

Authors:  Wei Wang; Xinshuai Wang; Yali Zhang; Dan Wang; Hui Gao; Lijuan Wang; Shegan Gao
Journal:  Onco Targets Ther       Date:  2016-03-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.